|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0783 | |
| C07K 16/28 | |||
| C07K 14/735 | |||
| C07K 14/725 |
| (11) | Number of the document | 2997132 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14727626.5 |
| Date of filing the European patent application | 2014-05-13 | |
| (97) | Date of publication of the European application | 2016-03-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/061409 |
| Date | 2014-05-13 |
| (87) | Number | WO 2014/184741 |
| Date | 2014-11-20 |
| (30) | Number | Date | Country code |
| 201313892805 | 2013-05-13 | US | |
| PCT/US2013/0407 | 2013-05-13 | WO | |
| PCT/US2013/0407 | 2013-05-13 | WO | |
| 201313942191 | 2013-07-15 | US |
| (72) |
GALETTO, Roman, FR
GOUBLE, Agnes, FR
GROSSE, Stephanie, FR
SCHIFFER-MANNIOUI, Cécile, FR
POIROT, Laurent, FR
SCHARENBERG, Andrew, US
SMITH, Julianne, FR
|
| (73) |
Cellectis,
8, rue de la Croix Jarry, 75013 Paris,
FR
|
| (54) | METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPY |
| METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPY |